Opendata, web and dolomites


ImmunoPET directed to specific subtypes of GABAA receptors as strategy for molecular mapping of behaviour and mental illness

Total Cost €


EC-Contrib. €






 GABARPET project word cloud

Explore the words cloud of the GABARPET project. It provides you a very rough idea of what is the project "GABARPET" about.

antibody    reveals    specificity    imaging    gaba    chain    cell    receptor    quantitative    changes    tracers    unveil    hallmarks    effect    gabarpet    tap    conventional    shed    characterization    surface    antibodies    gabaa    disorder    probes    severe    affinity    profound    molecular    cyclotron    sensitive    positron    disease    suggested    individuals    fragment    neuroimage    subunits    mostly    blood    alpha    phenotype    diagnosis    single    light    patients    sense    nevertheless    injection    models    labeled    papers    bbb    mental    setting    postmortem    transferrin    recombinant    society    neurological    immunopet    construct    knockout    invasive    wants    clear    small    biomarkers    di    lack    healthy    wild    receptors    intact    mice    additional    insights    pet    expression    18f    reveal    bispecific    diseases    vivo    barrier    brain    emission    transmigrate    gabaergic    directed    radionuclides    readily    89zr    differential    schizophrenia    psychiatric    scfv    penetrate    rodent    tomography    abnormalities    peripheral    limited    immune   

Project "GABARPET" data sheet

The following table provides information about the project.


Organization address
city: Turku
postcode: 20014

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Finland [FI]
 Total cost 304˙021 €
 EC max contribution 304˙021 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2019
 Funding Scheme MSCA-IF-EF-CAR
 Starting year 2020
 Duration (year-month-day) from 2020-09-01   to  2023-08-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    TURUN YLIOPISTO FI (Turku) coordinator 304˙021.00


 Project objective

Changes in GABA receptors are known hallmarks for numerous neurological diseases including schizophrenia which is a severe psychiatric disorder that has a profound effect on both the individuals affected and society. The diagnosis of schizophrenia is complex because of the loss of high specific biomarkers. Research papers have suggested that the differential expression of GABAA receptors in the brain is associated with this mental disease. The current evidence on GABAergic abnormalities in schizophrenia is mostly based on postmortem studies and, in this sense, in vivo measurements of GABAA receptor subunits can reveal additional insights. This project will develop Positron Emission Tomography (PET) probes which could unveil quantitative information about GABAA receptor expression in schizophrenia patients. However, the lack of imaging tracers with high affinity and specificity do not shed a clear light on the diagnosis in a traditional PET setting. In this sense, the immune-positron emission tomography (immunoPET) is a non-invasive technology based in antibody imaging which reveals a specific and sensitive molecular characterization of the cell surface phenotype in vivo. Nevertheless, its success in neuroimage is limited because of intact antibodies cannot penetrate the Brain Blood Barrier (BBB) in healthy conditions. However, GABARPET will tap into a small recombinant bispecific antibody construct targeting the GABAA receptors as well as the transferrin receptor because it is able to readily transmigrate across the BBB in vivo after peripheral injection. This project wants to develop di-single-chain variable fragment (di-scFv) directed to α1 and α2 subunits of GABAA receptors. Then, they will be labeled with conventional radionuclides produced by cyclotron as 18F and 89Zr. ImmunoPET probes will be used in wild-type mice, GABAA receptor knockout mice and different kind of rodent models of schizophrenia.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GABARPET" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "GABARPET" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

REMAKIN (2019)

REstoring myocardial repair capacity via the modulation of MAcrophage-mediated cytoKINe secretion.

Read More  

EMPaTHY (2019)

use of multiscale modElling to Minimize coke ProducTion during the methanol-to- HYdrocarbon process

Read More  


The dark side of partial ownership and financial investment in Europe: What price to pay for consumers and society?

Read More